Association of Cannabinoid Specialists
Makenna Campbell M.S., M.Ed is an accomplished professional with extensive experience in research, fundraising, and community engagement. Currently serving as an Investigator at the Cannabis Control Commission since August 2024 and Co-Director of the Student Department for the Association of Cannabinoid Specialists since April 2023, Makenna actively hosts events and collaborates on policy initiatives. Prior roles include Senior Research Analyst at the University of Massachusetts Lowell, where Makenna conducted major gift prospect research, and Development Associate at Merrimack Valley YMCA, with responsibilities in grant management and fundraising. Makenna's early career included teaching positions and a corps member role, reflecting a strong foundation in education and child development. Makenna holds a Master of Science in Medical Cannabis Science & Therapeutics from the University of Maryland Baltimore and a Master of Education in Community Engagement from Merrimack College, in addition to a Bachelor's Degree in Psychology from the University of Massachusetts Lowell.
This person is not in any teams
Association of Cannabinoid Specialists
The Association of Cannabis Specialists ensures the highest standards in the practice of cannabis medicine, safeguards patient care with clinical best practices, and interfaces with other stakeholders in the cannabis community. We believe that patients are uniquely vulnerable and have very different needs than recreational users. We provide evidence and experience-based education for patients, cannabis clinicians, referring clinicians, and lawmakers to help them understand cannabis medicine and make informed decisions. We are a political organization striving to implement best practices in the laws and regulations at the federal, state, and international levels. Our Core Values: • Patients are a vulnerable group who deserve the highest standard of medical care and products. • Recreational use is not the same as medical use. These groups have different goals and needs and must be addressed separately. • Prohibition of cannabis is a major public health hazard that has failed to decrease drug use and has led to unsupportable consequences. • Cannabis is medicine. It should be regulated like other medications and be available by prescription including in botanical form. • Cannabis products should not make unsubstantiated medical claims. Products should be required to meet strict standards of safety, bioavailability, and efficacy. • Dispensaries should operate like pharmacies. They should provide products that are safe and effective. They should not provide medical advice to patients. They should not contradict patients’ clinicians’ orders.